Industry collaboration is vital to supporting the mission of the ARLG in designing and executing clinical research that will reduce the public health threat of antibacterial resistance.
We welcome your partnership, advice, guidance, and protocol designs for the development of the next generation of drugs, devices, or diagnostic tools to combat antibacterial resistance.
ARLG provides a myriad of resources to industry (whether pharmaceutical, diagnostic or other companies), including guidance from ARLG experts, delivery of well-characterized bacterial isolates, access to clinical specimens, execution of MASTERMIND, and support for clinical trials and new research projects.
Please reach out to see what’s possible –ask us what we offer or let us know what you’d like to do. We can probably help!
Robin Patel, MD
Director of ARLG Diagnostics
and MASTERMIND Protocol